These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission. Haddjeri N, Blier P, de Montigny C. Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):20-9. PubMed ID: 9007838 [Abstract] [Full Text] [Related]
4. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas JP, Lejeune F. Eur J Neurosci; 2000 Mar; 12(3):1079-95. PubMed ID: 10762339 [Abstract] [Full Text] [Related]
7. The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. De Boer T, Nefkens F, Van Helvoirt A. Eur J Pharmacol; 1994 Feb 21; 253(1-2):R5-6. PubMed ID: 7912194 [Abstract] [Full Text] [Related]
8. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes. Esteban S, Lladó J, García-Sevilla JA. Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 21; 353(4):391-9. PubMed ID: 8935705 [Abstract] [Full Text] [Related]
9. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Haddjeri N, Blier P, de Montigny C. Int Clin Psychopharmacol; 1995 Dec 21; 10 Suppl 4():11-7. PubMed ID: 8930005 [Abstract] [Full Text] [Related]
11. Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan. de Boer TH, Nefkens F, van Helvoirt A, van Delft AM. J Pharmacol Exp Ther; 1996 May 21; 277(2):852-60. PubMed ID: 8627567 [Abstract] [Full Text] [Related]
12. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. de Boer T. Int Clin Psychopharmacol; 1995 Dec 21; 10 Suppl 4():19-23. PubMed ID: 8930006 [Abstract] [Full Text] [Related]
13. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. Rogoz Z, Wrobel A, Dlaboga D, Maj J, Dziedzicka-Wasylewska M. J Physiol Pharmacol; 2002 Mar 21; 53(1):105-16. PubMed ID: 11939713 [Abstract] [Full Text] [Related]
16. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain. Yamauchi M, Imanishi T, Koyama T. Neuropharmacology; 2012 Jun 21; 62(7):2278-87. PubMed ID: 22342987 [Abstract] [Full Text] [Related]
17. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Mongeau R, Blier P, de Montigny C. Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar 21; 347(3):266-72. PubMed ID: 8097564 [Abstract] [Full Text] [Related]
18. The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex. Kamińska K, Gołembiowska K, Rogóż Z. Pharmacol Rep; 2014 Dec 21; 66(6):984-90. PubMed ID: 25443725 [Abstract] [Full Text] [Related]